- Home
- VIR vs AMSC Comparison
VIR vs AMSC Comparison
Compare VIR & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIR | AMSC |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | 400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | VIR | AMSC |
|---|---|---|
| Price | $11.31 | $29.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $19.43 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.5M | 680.1K |
| Earning Date | 05-06-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.49 | ★ 1806.25 |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $68,556,000.00 | $900,000.00 |
| Revenue This Year | $270.22 | $34.98 |
| Revenue Next Year | N/A | $21.38 |
| P/E Ratio | ★ N/A | $147.45 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.75 | $24.87 |
| 52 Week High | $11.66 | $70.49 |
Technical Indicators
Market Signals| Indicator | VIR | AMSC |
|---|---|---|
| Relative Strength Index (RSI) | 73.93 | 40.05 |
| Support Level | $8.43 | $29.09 |
| Resistance Level | $11.66 | $33.70 |
| Average True Range (ATR) | 0.51 | 1.25 |
| MACD | 0.25 | 0.04 |
| Stochastic Oscillator | 93.86 | 26.14 |
Price Performance
Historical ComparisonAbout VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.